Correlation Between Protagonist Therapeutics and Humacyte
Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagonist Therapeutics and Humacyte, you can compare the effects of market volatilities on Protagonist Therapeutics and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Humacyte.
Diversification Opportunities for Protagonist Therapeutics and Humacyte
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Protagonist and Humacyte is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Humacyte go up and down completely randomly.
Pair Corralation between Protagonist Therapeutics and Humacyte
Given the investment horizon of 90 days Protagonist Therapeutics is expected to generate 0.85 times more return on investment than Humacyte. However, Protagonist Therapeutics is 1.17 times less risky than Humacyte. It trades about 0.03 of its potential returns per unit of risk. Humacyte is currently generating about -0.01 per unit of risk. If you would invest 4,039 in Protagonist Therapeutics on September 19, 2024 and sell it today you would earn a total of 30.00 from holding Protagonist Therapeutics or generate 0.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protagonist Therapeutics vs. Humacyte
Performance |
| Timeline |
| Protagonist Therapeutics |
| Humacyte |
Protagonist Therapeutics and Humacyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagonist Therapeutics and Humacyte
The main advantage of trading using opposite Protagonist Therapeutics and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
| Humacyte vs. Crinetics Pharmaceuticals | Humacyte vs. Viridian Therapeutics | Humacyte vs. Cytokinetics | Humacyte vs. Structure Therapeutics American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |